
QVC must face fraud and antitrust claims by actress Suzanne Somers, who claims the at-home shopping company used catch-and-kill tactics to favor another dietary supplement over hers, a Philadelphia federal judge ruled.
The lawsuit accuses QVC of agreeing to sell supplements made by Somers’ company SLC Sweet, then finding pretexts to reject purchase orders because it had an exclusive deal with an SLC competitor.
Somers, the former star of the TV sitcoms “Three’s Company” and “Step By Step,” filed the case in the US District Court for the Eastern District of Pennsylvania.
Originally, actress Suzanne Somers filed suit against QVC alleging it lured her into a deal as an attempt to remove her from the dietary supplement business and market its own supplement brands.
According to the civil action filed October 15 in the US District Court for the Eastern District of Pennsylvania, Suzanne Somers and SLC Sweet alleged breach of contract, violation of the Uniform Commercial Code, California’s Business and Professions Code, promissory estoppel, intentional interference with contractual relations, and violations of the Sherman Act against QVC.
The plaintiffs claim they were lured away from selling their products through the home shopping retailer Evine and asked to enter into a form purchase order agreement with QVC – all while a merger between QVC and HSN appeared to already be in the works. The suit states HSN already had a dietary supplement brand partner, Andrew Lessman.
Full Content: Legal News Line
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas